What should be done if a patient abruptly stops taking Mital (metformin 500 mg/myo‑inositol 600 mg) and Abilify (aripiprazole)?

Immediate Assessment and Management of Abrupt Discontinuation

If a patient suddenly stops metformin/myo-inositol (Mital) and aripiprazole (Abilify), immediately assess for withdrawal symptoms and metabolic decompensation, then restart medications with appropriate monitoring—do not leave the patient off these medications unless there is a specific contraindication.

Critical Initial Actions

For Aripiprazole (Abilify) Discontinuation

Monitor for psychiatric symptom rebound within 24-72 hours, including:

• Worsening psychosis, mania, or depression (depending on indication)
• Agitation or behavioral changes
• Return of baseline psychiatric symptoms 1

The FDA label explicitly warns against abrupt discontinuation without provider guidance 1. Research shows that abrupt discontinuation can lead to symptom exacerbation, particularly in the first week 2.

Key clinical pitfall: Patients may experience paradoxical agitation or symptom worsening when restarting aripiprazole after a period off medication, especially if they were previously on higher-potency dopamine antagonists 3. This is thought to be due to dopaminergic receptor hypersensitivity.

For Metformin/Myo-Inositol Discontinuation

Check blood glucose immediately and monitor for hyperglycemia over the next 24-48 hours. While metformin discontinuation does not cause a classic withdrawal syndrome, patients may experience:

• Rapid deterioration of glycemic control
• Return of hyperglycemic symptoms (polyuria, polydipsia, fatigue)
• Risk of diabetic ketoacidosis if glucose rises significantly 4, 5

Restart Protocol

Restarting Aripiprazole

Resume at the previous maintenance dose immediately if the patient has been off medication for less than 1 week 1. Do not restart at a lower dose and titrate up—this delays symptom control and increases risk of treatment failure.

• If off medication >1 week but <2 weeks: Resume at previous dose with close monitoring for the first 3-5 days
• If off medication >2 weeks: Consider restarting at previous dose but monitor more intensively for side effects in the first week 2, 6

Do not use a gradual titration approach when restarting after abrupt discontinuation—research shows that immediate reinitiation at therapeutic doses is safe and more effective than slow titration 6.

Restarting Metformin/Myo-Inositol

Resume metformin immediately at the previous dose if the patient has normal renal function (eGFR ≥30 mL/min/1.73 m²) and no acute illness 4, 5.

However, temporarily withhold metformin and seek urgent medical evaluation if the patient has:

• Vomiting, diarrhea, or dehydration
• Acute illness with volume depletion
• Any signs of lactic acidosis (weakness, muscle pain, difficulty breathing, unusual sleepiness)
• eGFR <30 mL/min/1.73 m² 7, 5

For myo-inositol component: Resume immediately—there are no withdrawal concerns or contraindications to immediate restart 8, 9.

If gastrointestinal symptoms were the reason for discontinuation: Resume metformin with food, consider extended-release formulation, or start at 500 mg daily and titrate up slowly over 2-4 weeks 10, 4, 11.

Monitoring After Restart

First 72 Hours

• Psychiatric status: Daily assessment for symptom control and side effects (aripiprazole)
• Blood glucose: Check fasting and pre-meal glucose if diabetic (metformin)
• Vital signs: Monitor for orthostatic hypotension (aripiprazole) 1
• Hydration status: Ensure adequate fluid intake

First 2 Weeks

• Weekly psychiatric assessment to ensure symptom stability on aripiprazole
• Monitor for impulse control problems (gambling, hypersexuality, compulsive eating, shopping)—these can emerge or worsen with aripiprazole and should prompt dose reduction or discontinuation 1, 12, 13
• Check HbA1c if not done in past 3 months (for metformin)
• Assess for gastrointestinal side effects from metformin 11

When NOT to Restart

Aripiprazole

• Patient developed neuroleptic malignant syndrome
• Severe tardive dyskinesia emerged
• Documented allergy or severe adverse reaction 1

Metformin

• eGFR <30 mL/min/1.73 m²
• Active lactic acidosis
• Severe hepatic impairment
• Acute heart failure or cardiogenic shock
• Ongoing severe illness with risk of lactic acidosis 7, 5

Patient Education Points

Emphasize that abrupt discontinuation of psychiatric medications can be dangerous and that any decision to stop should involve the prescriber 1. For metformin, educate about "sick day rules"—temporarily stop during acute illness with vomiting/diarrhea but resume within 24-48 hours of symptom resolution 7.

Common pitfall: Patients may stop aripiprazole due to perceived lack of effect or side effects without realizing that abrupt discontinuation can worsen their condition. Always explore the reason for discontinuation and address it directly rather than simply restarting medication.